https://peptidepolicywatch.com/2026/11/01/weekly-hhs-six-peptide-policy-published/Peptide Policy Watchen2026-11-01Peptide Week in 5 minutes: HHS opens a door for six peptides (October 26 to November 1, 2026) https://peptidepolicywatch.com/2026/11/01/natural-vs-synthetic-peptides-what-naturally-occurring-means/Peptide Policy Watchen2026-11-01"Naturally occurring" peptides: what the phrase tells you, and what it leaves out https://peptidepolicywatch.com/2026/10/31/why-most-drugs-in-human-trials-never-get-approved/Peptide Policy Watchen2026-10-31Why most drugs that enter human trials never get approved, and what that means for peptides https://peptidepolicywatch.com/2026/10/31/orforglipron-foundayo-fda-approval-priority-voucher/Peptide Policy Watchen2026-10-31Foundayo (orforglipron): the GLP-1 pill that isn't a peptide, and how a priority voucher sped up its approval